Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • Request More Information
  • Journalists

FDA Authorizes All ZYN Nicotine Pouch Products Currently Marketed by Swedish Match in the U.S.


News provided by

Swedish Match

28 Jan, 2025, 12:07 IST

Share this article

Share toX

Share this article

Share toX

  • FDA decision makes ZYN the first authorized nicotine pouch product
  • Science-based decision affirms that ZYN nicotine pouches are a better alternative for adults who smoke or use other traditional tobacco products

NEW DELHI, Jan. 28, 2025 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) authorized ZYN nicotine pouches making ZYN the first and only authorized nicotine pouch in the United States. The FDA's authorization of all ZYN nicotine pouches currently marketed by Swedish Match in the U.S. is an important step to protect the public health by providing better alternatives to cigarettes and other traditional tobacco products for adults 21+.

"An estimated 45 million Americans regularly consume nicotine and about 30 million of them smoke, the most harmful form of nicotine consumption," said Tom Hayes, president of Swedish Match North America, LLC. "The FDA's decision recognizes the role that ZYN can play in the protection of the public health by helping people switch from cigarettes and other traditional tobacco products."

The FDA authorized the following products:

  • ZYN Cool Mint 3 mg
  • ZYN Cool Mint 6 mg
  • ZYN Peppermint 3 mg
  • ZYN Peppermint 6 mg
  • ZYN Spearmint 3 mg
  • ZYN Spearmint 6 mg
  • ZYN Wintergreen 3 mg
  • ZYN Wintergreen 6 mg
  • ZYN Citrus 3 mg
  • ZYN Citrus 6 mg
  • ZYN Coffee 3 mg
  • ZYN Coffee 6 mg
  • ZYN Cinnamon 3 mg
  • ZYN Cinnamon 6 mg
  • ZYN Smooth 3 mg
  • ZYN Smooth 6 mg
  • ZYN Chill 3 mg
  • ZYN Chill 6 mg
  • ZYN Menthol 3 mg
  • ZYN Menthol 6 mg

The FDA's decision can be found here.

U.S. Marketing Practices Support 21+ Access Only

Swedish Match N.A. LLC is a subsidiary of Philip Morris International Inc. (PMI). PMI's U.S. affiliates are committed to responsible marketing practices focused on limiting access to adults 21 years of age and older. PMI's U.S. affiliates do not use social media influencers in the U.S. or people under the age of 35 in marketing materials. They also employ independent age-verification systems like "Double Verify" to direct digital advertising to those over 21, and owned digital platforms are age-gated at the point of access and restricted to current nicotine users of legal age. Swedish Match North America is a Manufacturer Advisory Council member of the We Card Program, a national nonprofit serving retailers of age-restricted products, and a founding board member and investor in TruAge®, a free retail technology that provides stores with a more accurate way of age verification, including the ability to detect fake IDs to ensure 21+ access only.

About Philip Morris International

Philip Morris International (PMI) is a leading international tobacco company working to deliver a smoke-free future and evolving its portfolio for the long term to include products outside tobacco and nicotine sector.

For more information, please visit www.pmi.com and www.pmiscience.com.

Modal title

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.